statistiche ricercatore

Continente	#
EU - Europa	602
NA - Nord America	570
AS - Asia	225
SA - Sud America	16
AF - Africa	2
Continente sconosciuto - Info sul continente non disponibili	2
OC - Oceania	1
Totale	1.418

Nazione	#
US - Stati Uniti d'America	539
GB - Regno Unito	203
DE - Germania	104
CN - Cina	100
IT - Italia	96
SE - Svezia	69
SG - Singapore	40
CA - Canada	31
IN - India	28
UA - Ucraina	27
KR - Corea	18
RU - Federazione Russa	18
FR - Francia	17
TR - Turchia	17
BE - Belgio	14
EU - Europa	14
IE - Irlanda	14
FI - Finlandia	12
ID - Indonesia	8
NL - Olanda	8
CO - Colombia	7
PL - Polonia	7
BR - Brasile	5
GR - Grecia	5
HK - Hong Kong	5
JP - Giappone	3
DK - Danimarca	2
IR - Iran	2
VE - Venezuela	2
A2 - ???statistics.table.value.countryCode.A2???	1
AL - Albania	1
AM - Armenia	1
AR - Argentina	1
AT - Austria	1
AU - Australia	1
CH - Svizzera	1
CI - Costa d'Avorio	1
CL - Cile	1
CZ - Repubblica Ceca	1
EE - Estonia	1
IL - Israele	1
KH - Cambogia	1
PK - Pakistan	1
RO - Romania	1
ZA - Sudafrica	1
Totale	1.431

Nome	#
Evolution of the HIV-1 protease region in heavily pretreated HIV-1 infected patients receiving Atazanavir	233
Comparative evaluation of seven resistance interpretation algorithms and their derived genotypic inhibitory quotients for the prediction of 48 week virological response to darunavir-based salvage regimens	233
In vitro efficacy of a non-conventional (folding) HIV-1 protease inhibitor without selection of resistance	192
Efficacy of Maraviroc (MVC) as intensification strategy in immunological non-responder (INR) HIV-1-infected patients treated with HAART	185
New macrocyclic amines showing activity as HIV entry inhibitors against wild type and multi-drug resistant viruses	177
Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy	166
The non-conventional (folding) protease inhibitor blocks the human immunodeficiency virus type-1 replication without evidence of resistance during in vitro passage	152
Susceptibility to a non-conventional (folding) protease inhibitor of human immunodeficiency virus type 1 isolates in vitro	146
Totale	1.484

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	100	0	0	0	0	0	0	30	11	24	22	10	3
2020/2021	162	10	9	17	5	11	9	11	6	26	12	40	6
2021/2022	140	17	9	10	8	8	7	15	7	15	14	8	22
2022/2023	200	35	29	16	24	13	28	22	4	18	1	6	4
2023/2024	93	4	5	1	5	17	10	8	8	1	2	4	28
2024/2025	107	10	28	3	34	20	12	0	0	0	0	0	0
Totale													1.484

IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca